pLHCX-gpASNase1 Citations (2)
Originally described in: Aspartate is an endogenous metabolic limitation for tumour growth.Sullivan LB, Luengo A, Danai LV, Bush LN, Diehl FF, Hosios AM, Lau AN, Elmiligy S, Malstrom S, Lewis CA, Vander Heiden MG Nat Cell Biol. 2018 Jul;20(7):782-788. doi: 10.1038/s41556-018-0125-0. Epub 2018 Jun 25. PubMed Journal
Articles Citing pLHCX-gpASNase1
| Articles |
|---|
| The CD73 immune checkpoint promotes tumor cell metabolic fitness. Allard D, Cousineau I, Ma EH, Allard B, Bareche Y, Fleury H, Stagg J. Elife. 2023 Jun 1;12:e84508. doi: 10.7554/eLife.84508. PubMed |
Aspartate availability drives differential engagement of the malate-aspartate shuttle.
Brunner JS, Bridgeman AE, Jackson BT, Chakraborty S, Fagoaga-Eugui M, Paras KI, Xie A, Arnold PK, Losner J, Finley LWS.
Mol Cell. 2026 Feb 26:S1097-2765(26)00099-7. doi: 10.1016/j.molcel.2026.02.004.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.